Unlocking life's possibilities
Intarcia Therapeutics, Inc. is a rapidly emerging biotech company committed to redesigning the treatment, prevention, and experience of chronic disease. The company operates with a 'No Analog' mindset, pushing boundaries with cross-disciplinary teams of scientists and entrepreneurs. Founded in 1997, it previously focused on implantable drug delivery devices and has raised significant funding.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2012
Create a free account to see which investors have funded this company.
Create Free Account
Painless, convenient transdermal patient administration of therapeutic proteins and vaccines
Escient is a clinical-stage pharmaceutical company focused on discovering and developing first-in...
Biotech developing in vivo CAR-T cell therapies. Acquired by AbbVie for $2.1B upfront in 2024.
Biopharmaceutical company focused on virology, oncology, and inflammation therapeutics.
Biotech developing EPiC peptide compounds to cross the blood-brain barrier for treating brain dis...
